Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001548644 | SCV001768590 | uncertain significance | not provided | 2019-09-24 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect |
Ambry Genetics | RCV002377911 | SCV002687729 | uncertain significance | Cardiovascular phenotype | 2023-09-18 | criteria provided, single submitter | clinical testing | The p.Q2875H variant (also known as c.8625G>C), located in coding exon 24 of the TNXB gene, results from a G to C substitution at nucleotide position 8625. The glutamine at codon 2875 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002501886 | SCV002777196 | uncertain significance | Ehlers-Danlos syndrome due to tenascin-X deficiency; Vesicoureteral reflux 8 | 2021-08-07 | criteria provided, single submitter | clinical testing |